http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101198588-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6e049624b468cbd0fb1c8895e4f2574
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C303-00
filingDate 2006-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdb80809223255dc5843ccf1393c4cca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ceb22fd164ca9f63a13890b3409443e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b03864cdbcfc85c519cb69cfbc43768
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ab3b15959a2d79dfbacd03c89e18d96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22d57b531f097ae85707a6836cfe258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e8b1c96f69e5dba8b380b4a369ce369
publicationDate 2013-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101198588-B
titleOfInvention Inhibitors of microsomal triglyceride transfer protein and apo-B secretion
abstract The present invention relates to compounds which are inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (Apo B) secretion. These compounds can be useful for the prevention and treatment of various diseases, particularly atherosclerosis and its clinical sequelae, for lowering serum lipids, and related ailments. The invention further relates to pharmaceutical compositions comprising the compounds and to methods of treating diseases, such as hypertriglyceridemia, hyperchylomicronemia, atherosclerosis, obesity, and related conditions using the compounds. A method for decreasing apolipoprotein B (apo B) secretion is also provided.
priorityDate 2005-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1181954-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1099443-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409703856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54346675
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413563544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18545462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467221575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468138883

Total number of triples: 24.